# Innoviva, Inc.: insider transactions

SEC CIK 1080014. Roles and transactions as reported on Form 4. Latest Form 4 filed 2023-01-13.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Armata Pharmaceuticals, Inc.](/companies/armp.md) | Director, 10% owner | 10 | 2021-01-26 | 2023-01-10 |
| [Armata Pharmaceuticals, Inc.](/companies/armp.md) | 10% owner | 2 | 2020-03-27 | 2020-03-27 |

## Transactions: 12

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2023-01-10 | [Armata Pharmaceuticals, Inc.](/companies/armp.md) | Purchase (P), derivative | not reported | $30,000,000.00 | not reported | [Form 4](/filings/0001104659-23-003540.md) |
| 2022-03-31 | [Armata Pharmaceuticals, Inc.](/companies/armp.md) | Purchase (P), derivative | 0 | $5.00 | $0 | [Form 4](/filings/0001567619-22-007861.md) |
| 2022-03-31 | [Armata Pharmaceuticals, Inc.](/companies/armp.md) | Purchase (P) | 5,385,208 | $5.00 | $26.9m | [Form 4](/filings/0001567619-22-007861.md) |
| 2022-02-09 | [Armata Pharmaceuticals, Inc.](/companies/armp.md) | Purchase (P), derivative | 1,807,396 | $5.00 | $9.0m | [Form 4](/filings/0001567619-22-003750.md) |
| 2022-02-09 | [Armata Pharmaceuticals, Inc.](/companies/armp.md) | Purchase (P) | 3,614,792 | $5.00 | $18.1m | [Form 4](/filings/0001567619-22-003750.md) |
| 2021-10-29 | [Armata Pharmaceuticals, Inc.](/companies/armp.md) | Purchase (P) | 1,212,122 | $3.30 | $4.0m | [Form 4](/filings/0001567619-21-019063.md) |
| 2021-03-17 | [Armata Pharmaceuticals, Inc.](/companies/armp.md) | Purchase (P), derivative | 4,285,935 | $3.25 | $13.9m | [Form 4](/filings/0001567619-21-006518.md) |
| 2021-03-17 | [Armata Pharmaceuticals, Inc.](/companies/armp.md) | Purchase (P) | 4,285,935 | $3.25 | $13.9m | [Form 4](/filings/0001567619-21-006518.md) |
| 2021-01-26 | [Armata Pharmaceuticals, Inc.](/companies/armp.md) | Purchase (P), derivative | 1,867,912 | $3.25 | $6.1m | [Form 4](/filings/0000899243-21-003595.md) |
| 2021-01-26 | [Armata Pharmaceuticals, Inc.](/companies/armp.md) | Purchase (P) | 1,867,912 | $3.25 | $6.1m | [Form 4](/filings/0000899243-21-003595.md) |
| 2020-03-27 | [Armata Pharmaceuticals, Inc.](/companies/armp.md) | Purchase (P), derivative | 7,717,661 | $2.87 | $22.1m | [Form 4](/filings/0001567619-20-007226.md) |
| 2020-03-27 | [Armata Pharmaceuticals, Inc.](/companies/armp.md) | Purchase (P) | 7,717,661 | $2.87 | $22.1m | [Form 4](/filings/0001567619-20-007226.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 31, 2026, 23:40 ET. No prices; not investment advice.